tert-Butyl (5-(hydroxymethyl)thiazol-2-yl)carbamate, 95.0%, 250mg

3-Bromo-5-nitrotoluene, 95.0%, 5g

2-Isobutyrylcyclohexanone, 96.0%, 5g

11H-BENZO[B]FLUOREN-11-ONE, 99%, 5g

Microliter syringe GASTIGHT® series 1000, 5.0 ml, 1005 TLL, 1 piece

5-(2-Methylpropyl)-1,3-thiazol-2-amine, 97%, 5g

4-Bromo-2-methyl-1H-indole, 95.0%, 250mg

2-Chloro-6-fluoro-3-hydroxyphenylboronic acid pinacol ester, 97%, 250mg

1-(4-tert-Butylphenyl)propan-2-one, 97.0%, 1g

4-Methylumbelliferyl caprylate, 98%, 25g

4-(trans-4-Propylcyclohexyl)cyclohexanone>98.0%(GC)1g

N-((((9H-fluoren-9-yl)methoxy)carbonyl)-L-alanyl)-N-(2,4-dimethoxybenzyl)glycine, 98%, 5g

1,5-Pentanedioic acid monobenzyl ester, 95.0%, 5g